Nav: Home

Potential markers identified for early detection and prevention of liver cancer

October 31, 2018

Liver cancer is the second leading cause of cancer-related mortality worldwide, claiming 700,000 lives each year. Most cases are discovered too late for a cure -- but now a study offers hope of early detection, and targets for new treatments. Published in Frontiers in Cell and Developmental Biology, the results show a dramatic increase in expression of sugar-burning 'glycolytic' enzymes in precancerous cirrhotic livers. This increase is associated with a significantly higher risk of developing hepatocellular carcinoma (HCC) -- the main type of liver cancer -- and could lead to a biomarker which identifies those at risk of malignancy.

"We know that 90% of all hepatocellular carcinoma cases start with liver cirrhosis," explains study senior authors Dr Salvatore Papa of the University of Leeds and Dr Concetta Bubici of Brunel University London, UK. "So by pinpointing when cirrhosis progresses to cancer, we could improve early detection and treatment -- with surgery, chemo and radiotherapy, but perhaps also with new treatments which reverse the transition."

Metabolic changes in cancer cells

In cirrhosis, chronic damage caused by hepatitis viruses B or C, alcohol, or obesity leads to scarring and formation of regenerative nodules in the liver. High cell turnover in these nodules, with accumulation of genetic damage, can eventually produce cancerous cells.

"We set out to find features of cirrhotic cells that might predict cancerous change," says Papa.

For nearly a century, scientists have recognized that cancer cells shift the way they generate energy. Normally the body obtains energy from macronutrients -- sugars, fats, proteins and their intermediaries -- primarily using oxygen. But our cells can also extract energy from sugars without using oxygen. This anaerobic process, called glycolysis, produces the lactate that 'burns' our muscles during intense exercise -- and is also used by cancers to fuel their rampant growth.

"Like virtually all cancers, highly-proliferating HCC cells seem to readjust their energy metabolism towards glycolysis, irrespective of oxygen availability."

The cause of this shift in glucose metabolism -- known as the Warburg effect -- remains unknown, but inflammation is thought to play a role.

"Given that cirrhosis is an inflammatory process, we decided to look at whether the metabolic shift to glycolysis is present already in cirrhotic cells -- and whether this predicts progression to hepatocellular carcinoma."

Cancer metabolic changes are present in cirrhotic cells

Papa and colleagues analyzed normal, cirrhotic and cancerous (HCC) liver samples from patients followed up over 10 years following a liver biopsy.

"To have a complete overview of energy metabolism changes in HCC and premalignant stages of disease, we measured the expression of genes encoding enzymes involved in glycolysis and other metabolic pathways."

They found that glycolysis-related genes -- including hexokinase 2 (HK2), aldolase A (ALDOA) and pyruvate kinase M2 (PKM2) -- are highly expressed not only in HCC, but also in cirrhosis as compared to normal liver samples.

"In other words: the shift to glycolysis occurs in the precancerous stage," says Bubici.

Even more striking, the level of expression of glycolysis-related genes showed positive correlation with progression of cirrhosis to HCC -- and with poor outcome in those with HCC already at the time of biopsy.

"This suggests expression of glycolytic enzymes could be used as a new biomarker to predict the risk of later development of HCC in patients with cirrhosis," claims Bubici.

Towards early detection

The team stresses the study is preliminary: "Further studies are needed to establish whether these changes in gene expression are borne out as changes in glycolytic activity."

Nevertheless, the findings reveal a promising means to improve HCC survival through early detection and treatment. According to Papa, the shift to a glycolytic expression profile in cirrhotic cells could even be a target for new HCC therapies.

"For example, clinical trials are currently underway to explore the effect of statins -- which are used to help prevent cardiovascular disease -- on HCC development in cirrhotic patients or HCC recurrence following surgical removal.

"It is very likely that by blocking cholesterol synthesis, statins would also suppress glycolysis as these chemical pathways overlap. If these trials show that statins reduce HCC risk, further studies would be necessary to establish whether inhibition of glycolysis in cirrhotic cells is responsible," says Papa.
-end-
The research is part of a special article collection on the Warburg effect, of which Papa and Bubici are co-editors.

Please include a link to the original research article in your reporting: https://www.frontiersin.org/articles/10.3389/fcell.2018.00138/full

Frontiers is an award-winning Open Science platform and leading open-access scholarly publisher. Our mission is to make high-quality, peer-reviewed research articles rapidly and freely available to everybody in the world, thereby accelerating scientific and technological innovation, societal progress and economic growth. For more information, visit http://www.frontiersin.org and follow @Frontiersin on Twitter.

Frontiers

Related Cancer Articles:

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
More Cancer News and Cancer Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

Accessing Better Health
Essential health care is a right, not a privilege ... or is it? This hour, TED speakers explore how we can give everyone access to a healthier way of life, despite who you are or where you live. Guests include physician Raj Panjabi, former NYC health commissioner Mary Bassett, researcher Michael Hendryx, and neuroscientist Rachel Wurzman.
Now Playing: Science for the People

#543 Give a Nerd a Gift
Yup, you guessed it... it's Science for the People's annual holiday episode that helps you figure out what sciency books and gifts to get that special nerd on your list. Or maybe you're looking to build up your reading list for the holiday break and a geeky Christmas sweater to wear to an upcoming party. Returning are pop-science power-readers John Dupuis and Joanne Manaster to dish on the best science books they read this past year. And Rachelle Saunders and Bethany Brookshire squee in delight over some truly delightful science-themed non-book objects for those whose bookshelves are already full. Since...
Now Playing: Radiolab

An Announcement from Radiolab